1. Home
  2. CASH vs GLPG Comparison

CASH vs GLPG Comparison

Compare CASH & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$85.93

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$28.46

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
GLPG
Founded
1954
1999
Country
United States
Belgium
Employees
N/A
452
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CASH
GLPG
Price
$85.93
$28.46
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$107.50
$36.50
AVG Volume (30 Days)
176.3K
118.8K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
0.23%
N/A
EPS Growth
18.88
N/A
EPS
1.57
N/A
Revenue
$839,894,000.00
N/A
Revenue This Year
$7.56
N/A
Revenue Next Year
$6.02
N/A
P/E Ratio
$55.36
N/A
Revenue Growth
11.29
N/A
52 Week Low
$65.93
$24.74
52 Week High
$101.26
$37.78

Technical Indicators

Market Signals
Indicator
CASH
GLPG
Relative Strength Index (RSI) 35.03 41.03
Support Level $82.68 $27.98
Resistance Level $94.84 $34.04
Average True Range (ATR) 3.12 0.50
MACD -1.19 0.06
Stochastic Oscillator 8.83 48.72

Price Performance

Historical Comparison
CASH
GLPG

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: